wpe50.jpg (1913 bytes)      TigerSoft News Service    10/24/2014    www.tigersoft.com    

         Investors Just Cannot Trust
                Biotech CEOs

              Arrowhead Research in 2014 Is An All Too Typical Case.

                TigerSoft Is Your Best Protection against
                         "Pumping and Dumping." 

                            by William Schmidt, Ph.D.   (Columbia University) ...
                      Inventor of TigerSoft Insider Trading Detection Saoftware.

wpe4F.jpg (33251 bytes)               Tiger Software 

   Helping Investors since 1981
       Make Your Retirement Grow
    Suggestions: 
       Peerless Stock Market Timing: 1928-1966  
       
       7 Paths To Making 25+%/Yr. Using TigerSoft 
       Index Options             
       FOREX trading         
       Investing Longer-Term          
       Mutual Funds
       Speculative Stocks     
       Swing Trading       
       Day Trading         
       Stock Options           
       Commodity Trading        

                    At our August 3rd 2013 Tiger User Group meeting in San Diego,
                we noted the sudden emergence of ARWR as a bullish Explosive Super Stock.
                It also regularly appeared on the elite Bullish MAXCP page of our nightly Hotline.
                The wall of high very high Accumulation, Closing Power and Relative Strength
                new highs were hard to miss using Tiger's Power Ranker. At the time, all we knew
                was that this was a small biotech with a promising potential treatment for the
                world-wide scourge of hapatitis..

                                           ARWR 2013 - $2 to $13.
ARWRBEG.BMP (972054 bytes)

                     
                      While it's true that bullish investors will probably strain
                 to hear whatever they want to hear in a biotech's pronouncements,
                 clearly a biotech company should not raise expectations about a
                 new drug's likely efficacy to unrealistic and false levels.  That
                 appears to be what Arrowhead Research did. 

                                          ARWR 2014 - $13 to $26 to $6.

ARWR.BMP (912114 bytes)

                        At TigerSoft, we had no special knowledge about the stock
                 when we bought into it under $15, just when the unrealistic expectations
                 about the company's anti-Hepatitis-C drug were being circulated
                 on Wall Street.  When the stock rose above $25, our TigerSoft
                 Closing Power broke its uptrend and we happily took profits. 
                 From time to time, I looked at AARW's chart, but never found that
                 it showed any new signs of Insider Buying (very high levels from
                 Tiger's Accumulation Index) and so we never bought it.

                        What I did see was a stock that could not recover back above
                $18.   And a stock that very feeble Accumulation readings in
                September when it traded back up to $16.  There was no reason,
                whatsoever,   to buy the stock.  Tiger users of the swings and trends
                of Closing Power would have been short the stock when it suddenly
                plunged 50% in one day when the company's real results from drug
                trials were released.

                        As one would expect, there was an outcry against the company
                and its CEOs.  It also so not take long before lawsuits were initiated
                claiming corporate fraud and insider trading.

        
                                     Insider Sales before The Bad News Came Out
                                       http://www.secform4.com/insider-trading/879407.htm

2014-10-01
Sale		 2014-10-01
7:38 pm		 ARROWHEAD RESEARCH CORP ARWR McKenney Charles
(Director)		 2,500 $14.7 $36,748 17,220
(Direct)		 View
2014-09-30
Sale		 2014-09-30
5:59 pm		 ARROWHEAD RESEARCH CORP ARWR Lewis David L.
(Chief Scientific Officer)		 15,000 $15.02 $225,350 0
(Direct)		 View
2014-09-26
Sale		 2014-09-30
5:58 pm		 ARROWHEAD RESEARCH CORP ARWR GIVEN DOUGLAS B
(Director)		 2,000 $15.24 $30,480 20,000
(Direct)		 View
2014-08-15
Sale		 2014-08-19
5:15 pm		 ARROWHEAD RESEARCH CORP ARWR Myszkowski Kenneth Allen
(CFO)		 40,000 $14.02 $560,860 71,500
(Direct)		 View
2014-08-15
Sale		 2014-08-19
5:15 pm		 ARROWHEAD RESEARCH CORP ARWR GIVEN DOUGLAS B
(Director)		 5,000 $13.9 $69,500 20,000
(Direct)		 View
2014-06-09
Sale		 2014-06-10
9:28 pm		 ARROWHEAD RESEARCH CORP ARWR McKenney Charles
(Director)		 22,000 $14.32 $315,005 17,220
(Direct)		 View
2014-02-12
Sale		 2014-02-12
7:15 pm		 ARROWHEAD RESEARCH CORP ARWR Myszkowski Kenneth Allen
(CFO)		 16,000 $18.77 $300,290 71,500
(Direct)		 View


                 in price
the case with